DOCSLIB.ORG

Transcriptional Heterogeneity of Mast Cells and Basophils Upon Activation Krishan D

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Transcriptional Heterogeneity of Mast Cells and Basophils Upon Activation Krishan D Transcriptional Heterogeneity of Mast Cells and Basophils upon Activation Krishan D. Chhiba, Chia-Lin Hsu, Sergejs Berdnikovs and Paul J. Bryce This information is current as of September 23, 2021. J Immunol 2017; 198:4868-4878; Prepublished online 5 May 2017; doi: 10.4049/jimmunol.1601825 http://www.jimmunol.org/content/198/12/4868 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2017/05/05/jimmunol.160182 Material 5.DCSupplemental References This article cites 33 articles, 12 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/198/12/4868.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 23, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Transcriptional Heterogeneity of Mast Cells and Basophils upon Activation Krishan D. Chhiba, Chia-Lin Hsu, Sergejs Berdnikovs, and Paul J. Bryce Mast cells and basophils are developmentally related cells whose activation is a hallmark of allergy. Functionally, mast cells and basophils overlap in their ability to produce several mediators, including histamine and granule proteases, but studies have increas- ingly demonstrated nonredundant roles. To characterize the transcriptional heterogeneity of mast cells and basophils upon their activation, we performed large-scale comparative microarrays of murine bone marrow–derived mast cells and bone marrow– derived basophils (BMBs) at rest, upon an adaptive-type activation (IgE cross-linking), or upon an innate-type activation (IL-33 stimulation). Hierarchical clustering demonstrated that bone marrow–derived mast cells and BMBs shared specific activation- associated transcriptional signatures but differed in other signatures both between cell type and between activation mode. In bone marrow–derived mast cells, IgE cross-linking upregulated 785 genes, including Egr2, Ccl1, and Fxyd6, whereas IL-33 Downloaded from stimulation induced 823 genes, including Ccl1, Egr2, and Il1b. Focused bioinformatics pathway analysis demonstrated that IgE activation aligned with processes such as oxidative phosphorylation, angiogenesis, and the p53 pathway. The IL-33–activated transcriptome was enriched in genes commonly altered by NF-kB in response to TNF, by IL-6 via STAT3, and in response to IFN-g. Furthermore, BMBs activated via IgE cross-linking selectively induced immune response genes Ccl1, Il3, and Il2 compared with IL-33–stimulated BMBs. Principal-component analysis revealed key cell- and activation-specific clustering. Overall, our data demonstrate that mast cells and basophils have cell- and activation-specific transcriptional responses and suggest that context- http://www.jimmunol.org/ specific gene networks and pathways may shape how the immune system responds to allergens and innate cytokines. The Journal of Immunology, 2017, 198: 4868–4878. ast cells and basophils are critical effector cells in type to months. Conversely, mature basophils circulate in the blood be- I immediate hypersensitivity reactions and associate fore being recruited to tissues and have a shorter lifespan (60–70 h). M with allergic disease pathology. The developmental As a result of their developmental similarity, circulating basophils pathways of mast cells and basophils are closely related but are also are often used as surrogates to study tissue-resident mast cell re- the subject of continuing controversy (1). In the bone marrow, mast activity [e.g., the basophil activation test for diagnosing food al- cells and basophils are commonly considered to begin as common lergy–associated reactivity (7)], but the similarity or heterogeneity by guest on September 23, 2021 myeloid progenitor cells, progress to granulocyte-monocyte pro- between the two cell types is relatively unknown. genitors, and become granulocyte progenitors. Functionally, gran- Generally, mast cells and basophils respond to many of the same ulocyte progenitors have been shown to differentiate into basophils stimuli, and their functional roles appear to overlap. The best- or mast cell progenitors (MCPs) (2, 3). However, this model has studied shared mechanism of activation between the cell types is been challenged by studies at the single-cell level that define MCP cross-linking of the FcεRI receptor, which promotes the release of potential within a common myeloid population and not in the histamine, as well as other granule mediators, eicosanoids, and granulocyte/macrophage progenitor population (4). Common pro- inflammatory cytokines. In addition to activation through FcεRI, genitors are also found in the spleen and can generate basophils and mast cells and basophils express ST2, the receptor for IL-33. MCPs (5, 6). MCPs are released into the circulation and mature IL-33 is an “epithelial-derived” cytokine that promotes type once they are in tissues; mature mast cells have a lifespan of weeks 2–associated immune responses and has been strongly linked to allergy (8). Upon IL-33–mediated activation, mast cells have been shown to exhibit enhanced adhesion, survival, maturation, and Division of Allergy and Immunology, Department of Medicine, Northwestern Uni- production of several proinflammatory cytokines (9, 10). In ba- versity Feinberg School of Medicine, Chicago, IL 60611 sophils, IL-33–mediated activation has been described as pro- ORCID: 0000-0002-6997-7667 (K.D.C.). moting migration toward eotaxin and enhancing degranulation Received for publication October 25, 2016. Accepted for publication April 10, 2017. upon concurrent IgE-mediated activation (11). For cytokine pro- This work was supported by National Institutes of Health Grant R01AI105839 (to P.J.B.). duction, basophils were also shown to respond poorly to IL-33 The microarray data presented in this article have been submitted to the National compared with IgE-mediated activation, but a relatively small Center for Biotechnology Information’s Gene Expression Omnibus (https://www. number of mediators were studied (12, 13). Therefore, defining ncbi.nlm.nih.gov/geo/) under accession number GSE96696. the transcriptional activation signatures of mast cells and baso- Address correspondence and reprint requests to Dr. Paul J. Bryce, Division of phils using a systems biology–based approach is likely to help Allergy and Immunology, Feinberg School of Medicine, Northwestern University, 240 E. Huron Street, Chicago, IL 60611. E-mail address: [email protected] understand the possible contributions of each cell type and the The online version of this article contains supplemental material. mode of activation to the progression of allergic diseases. Abbreviations used in this article: AREG, amphiregulin; BMB, bone marrow–derived Recent evidence has shown that resting mast cells and basophils basophil; BMMC, bone marrow–derived mast cell; GSEA, Gene Set Enrichment actually have relatively low transcriptional homology in mice and Analysis; log2FC, log2 fold change; m, mouse; MCP, mast cell progenitor; PCA, humans (14, 15), implying that they might be much more distinct principal component analysis; ST2KO, ST2-knockout; WT, wild-type. than once thought. However, the similarities and/or differences in Copyright Ó 2017 by The American Association of Immunologists, Inc. 0022-1767/17/$30.00 their transcriptional signatures upon activation are unknown. It is www.jimmunol.org/cgi/doi/10.4049/jimmunol.1601825 The Journal of Immunology 4869 well appreciated that mast cells have functions in health and using an Agilent 2100 Bioanalyzer. cDNA was synthesized with qScript disease. In line with their role as sentinel cells, mast cells encode cDNA Supermix (Quanta Biosciences). Gene expression was verified for pathways for the synthesis of a diverse array of mediators. They select genes by real-time PCR using an ABI 7500 instrument and TaqMan probes (both from Applied Biosystems). are critical players in the symptoms of anaphylaxis, mediate re- sistance to infection, and promote tumor rejection. Relatively less Microarray experiments and statistical analyses is known about basophil functions. Basophils rapidly secrete IL-4 RNA was hybridized to Illumina MouseWG-6 v2.0 arrays (catalog number and IL-13 upon IgE-mediated activation, play a role in the host BD-201-0202). Preprocessing steps, including quality control, background defense against parasites, and promote Th2 responses through adjustment, and quantile normalization, were performed using the array altering Ag presentation (13, 16). Although mast cells and baso- analysis tools available at http://www.arrayanalysis.org using the lumi phils are believed to have nonredundant roles in immune regula- package and bgAdjust function (18). Variance stabilization was managed with a log2 transformation. Normalized data were filtered to remove unex- tion, the evidence
Load more

Recommended publications
  • Mouse and Human Fcr Effector Functions
    Pierre Bruhns Mouse and human FcR effector € Friederike Jonsson functions Authors’ addresses Summary: Mouse and human FcRs have been a major focus of Pierre Bruhns1,2, Friederike J€onsson1,2 attention not only of the scientific community, through the cloning 1Unite des Anticorps en Therapie et Pathologie, and characterization of novel receptors, and of the medical commu- Departement d’Immunologie, Institut Pasteur, Paris, nity, through the identification of polymorphisms and linkage to France. disease but also of the pharmaceutical community, through the iden- 2INSERM, U760, Paris, France. tification of FcRs as targets for therapy or engineering of Fc domains for the generation of enhanced therapeutic antibodies. The Correspondence to: availability of knockout mouse lines for every single mouse FcR, of Pierre Bruhns multiple or cell-specific—‘a la carte’—FcR knockouts and the Unite des Anticorps en Therapie et Pathologie increasing generation of hFcR transgenics enable powerful in vivo Departement d’Immunologie approaches for the study of mouse and human FcR biology. Institut Pasteur This review will present the landscape of the current FcR family, 25 rue du Docteur Roux their effector functions and the in vivo models at hand to study 75015 Paris, France them. These in vivo models were recently instrumental in re-defining Tel.: +33145688629 the properties and effector functions of FcRs that had been over- e-mail: [email protected] looked or discarded from previous analyses. A particular focus will be made on the (mis)concepts on the role of high-affinity Acknowledgements IgG receptors in vivo and on results from antibody engineering We thank our colleagues for advice: Ulrich Blank & Renato to enhance or abrogate antibody effector functions mediated by Monteiro (FacultedeMedecine Site X.
    [Show full text]
  • Basophil Activation Receptors Inhibit Mouse and Human Γ Fc
    Fcγ Receptors Inhibit Mouse and Human Basophil Activation Lydie Cassard, Friederike Jönsson, Ségolène Arnaud and Marc Daëron This information is current as of September 24, 2021. J Immunol published online 20 August 2012 http://www.jimmunol.org/content/early/2012/08/20/jimmun ol.1200968 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2012/08/20/jimmunol.120096 Material 8.DC1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 24, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published August 20, 2012, doi:10.4049/jimmunol.1200968 The Journal of Immunology Fcg Receptors Inhibit Mouse and Human Basophil Activation Lydie Cassard,*,†,1 Friederike Jo¨nsson,*,†,1 Se´gole`ne Arnaud,*,† and Marc Dae¨ron*,† Besides high-affinity IgE receptors (Fc«RI), human basophils express activating (FcgRIIA) and inhibitory (FcgRIIB) low-affinity IgG receptors. IgG receptors (FcgR) were also found on mouse basophils, but not identified.
    [Show full text]
  • Food Allergy and Food Intolerance: Specific Versus Innate Immunity Roger Davis Deutsch
    The Original Internist article Food Allergy and Food Intolerance: specific versus innate immunity Roger Davis Deutsch Nomenclature The concept of an allergy was fairly well understood when von Pirquet, an Austrian physician, first introduced the term in 1906. It was intended to denote an altered reaction to a normally innocuous substance. Two decades later allergists in Europe agreed to narrow the definition to apply only to such an altered reaction as may be characterized by an immediate onset of symptoms. Contemporary physicians recognize a distinction between immediate and delayed-type altered reactions in their nomenclature by applying the terms, “intolerance” or “sensitivity” in the case of common reactions to foods and other chemicals, where symptom onset is delayed and typically of a less acute nature than that which has come to be known as a “true” allergy, classical allergy, or Type I hypersensitivity, according to the Gell and Coombs classification system. Although both phenomena involve an aberrant immune response, the mechanisms underlying each are quite different. Broadly speaking, classical allergy is a function of the specific immune system, whilst intolerance involves activation of the innate branch of the immune system. Classical allergy is a function of the specific immune system The most prominent hallmark of specific immunity is memory; hence the rationale underlying immunization. It is termed, “specific” because it makes use of pathogen- or allergen-specific binding sites on Immunoglobulins or lymphocyte receptor molecules in the process of recognition. Prior exposure to the activating substance is therefore necessary in order to “prime” or elicit a subsequent response of the specific immune system.
    [Show full text]
  • Decreased Intracellular Histamine Concentration and Basophil Activation in Anaphylaxis
    Allergology International 69 (2020) 78e83 Contents lists available at ScienceDirect Allergology International journal homepage: http://www.elsevier.com/locate/alit Original Article Decreased intracellular histamine concentration and basophil activation in anaphylaxis Satoshi Yamaga a, Yuhki Yanase b, Kaori Ishii b, Shinichiro Ohshimo a, Nobuaki Shime a, * Michihiro Hide b, a Department of Emergency and Critical Care Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan b Department of Dermatology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan article info abstract Article history: Background: Histamine is a crucial mediator in the development of anaphylaxis. Although histamine is Received 9 February 2019 promptly degraded because of its short half-life in plasma, basophils, which release histamine, remain in Received in revised form the blood for days. To explore basophils as a potential marker and their involvement in the pathogenesis 18 May 2019 of anaphylaxis, we evaluated the intracellular histamine concentration and the degree of basophil Accepted 21 May 2019 activation in anaphylaxis patients. Available online 24 June 2019 Methods: We conducted a caseecontrol study enrolling anaphylaxis patients and healthy controls. Basophil activation was evaluated by flow cytometry using up-regulation of CD203c expression. Keywords: Anaphylaxis Results: We enrolled 23 patients and measured their blood histamine concentration. Basophil activation Basophil activation was analyzed in seven of 23 patients. The median intracellular histamine concentrations at admission CD203c were significantly lower in patients compared with controls (16.4 ng/mL [interquartile range {IQR}, 2.70 Intracellular histamine to 34.0] vs. 62.3 ng/mL [IQR, 46.0 to 85.1]; p < 0.0001).
    [Show full text]
  • Road Map for the Clinical Application of the Basophil Activation Test in Food Allergy
    Road map for the clinical application of the basophil activation test in food allergy The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Santos, A. F., and W. G. Shreffler. 2017. “Road map for the clinical application of the basophil activation test in food allergy.” Clinical and Experimental Allergy 47 (9): 1115-1124. doi:10.1111/cea.12964. http://dx.doi.org/10.1111/cea.12964. Published Version doi:10.1111/cea.12964 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:34492249 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA DOI: 10.1111/cea.12964 REVIEW Road map for the clinical application of the basophil activation test in food allergy A. F. Santos1 | W. G. Shreffler2 1Department of Paediatric Allergy, King’s College London/Guy’s and St Thomas’ Summary Hospital, London, UK The diagnosis of IgE-mediated food allergy based solely on the clinical history and the 2Department of Pediatrics, Division of documentation of specific IgE to whole allergen extract or single allergens is often Allergy and Immunology, Food Allergy Center, Massachusetts General Hospital, ambiguous, requiring oral food challenges (OFCs), with the attendant risk and inconve- Harvard Medical School, Boston, MA, USA nience to the patient, to confirm the diagnosis of food allergy. This is a considerable Correspondence proportion of patients assessed in allergy clinics.
    [Show full text]
  • Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome
    cells Article Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome Heather J. Bax 1,2 , Jitesh Chauhan 1,2, Chara Stavraka 1,2,3 , Atousa Khiabany 1,2, Mano Nakamura 1, Giulia Pellizzari 1, Kristina M. Ilieva 1,4, Sara Lombardi 5, Hannah J. Gould 6,7, Christopher J. Corrigan 7,8, Stephen J. Till 7,8, Sidath Katugampola 9 , Paul S. Jones 9, Claire Barton 9,10, Anna Winship 3, Sharmistha Ghosh 3, Ana Montes 3, Debra H. Josephs 1,2,3, James F. Spicer 2,3 and Sophia N. Karagiannis 1,4,* 1 St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, London SE1 9RT, UK; [email protected] (H.J.B.); [email protected] (J.C.); [email protected] (C.S.); [email protected] (A.K.); [email protected] (M.N.); [email protected] (G.P.); [email protected] (K.M.I.); [email protected] (D.H.J.) 2 School of Cancer & Pharmaceutical Sciences, King’s College London, Guy’s Hospital, London SE1 9RT, UK; [email protected] 3 Departments of Medical Oncology and Clinical Oncology, Guy’s and St Thomas’ NHS Foundation Trust, London SE1 9RT, UK; [email protected] (A.W.); [email protected] (S.G.); [email protected] (A.M.) 4 Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King’s College London, Guy’s Cancer Centre, London SE1 9RT, UK 5 Guy’s and St Thomas’ Oncology & Haematology Clinical Trials (OHCT), Guy’s Cancer Centre, London SE1 9RT, UK; [email protected] 6 Randall Centre for
    [Show full text]
  • Measurement of Mast Cell and Basophil Activation in Vitro As Means for Investigation of Drug Hypersensitivity
    University of Southampton Faculty of Medicine Measurement of mast cell and basophil activation in vitro as means for investigation of drug hypersensitivity by Desiree Ludwig Thesis of the degree of Master of Philosophy May 2015 University of Southampton, Faculty of Medicine, Master of Philosophy, Desiree Ludwig Measurement of mast cell and basophil activation in vitro as means for investigation of drug hypersensitivity Abstract Allergic drug reactions to drugs are becoming more frequent throughout the world and are among the most common and serious form of immuno-pathological process in modern clinical medicine. These reactions can lead to life-threatening anaphylaxis which can occur within minutes of receiving the drug. Symptoms provoked by the explosive release of mediators from mast cells and basophils release may include itchiness, angioedema, difficulty breathing and circulatory collapse. There are few reliable laboratory tests available to identify those with drug hypersensitivity who may be at risk of anaphylactic shock, or even to establish if such a reaction has occurred. Confirmation of drug hypersensitivity by skin testing or oral challenge can put the patient at risk of serious reaction, and as such are expensive and performed at few centres. The aim of the study was to seek to develop new tests for drug allergy based on assessment of mast cell or basophil activation either in vitro or in vivo. Patients were recruited who were suspected of having suffered an allergic reaction to medicine and who were undergoing skin testing or oral drug challenge. Blood was collected before and following the challenge, the nature of symptoms provoked were recorded, and clinical history and demographic data obtained.
    [Show full text]
  • Biomarkers of the Involvement of Mast Cells, Basophils and Eosinophils in Asthma and Allergic Diseases
    Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Metcalfe, D. D., R. Pawankar, S. J. Ackerman, C. Akin, F. Clayton, F. H. Falcone, G. J. Gleich, et al. 2016. “Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases.” The World Allergy Organization Journal 9 (1): 7. doi:10.1186/s40413-016-0094-3. http://dx.doi.org/10.1186/ s40413-016-0094-3. Published Version doi:10.1186/s40413-016-0094-3 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:25658402 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Metcalfe et al. World Allergy Organization Journal (2016) 9:7 DOI 10.1186/s40413-016-0094-3 REVIEW Open Access Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases Dean D. Metcalfe1*, Ruby Pawankar2, Steven J. Ackerman3, Cem Akin4, Frederic Clayton5, Franco H. Falcone6, Gerald J. Gleich7, Anne-Marie Irani8, Mats W. Johansson9, Amy D. Klion10, Kristin M. Leiferman11, Francesca Levi-Schaffer12, Gunnar Nilsson13, Yoshimichi Okayama14, Calman Prussin1, John T. Schroeder15, Lawrence B. Schwartz16, Hans-Uwe Simon17, Andrew F. Walls18 and Massimo Triggiani19 Abstract Biomarkers of disease activity have come into wide use in the study of mechanisms of human disease and in clinical medicine to both diagnose and predict disease course; as well as to monitor response to therapeutic intervention.
    [Show full text]
  • Improved Diagnosis and Therapy of Hymenoptera Venom Allergy by Component-Resolved Approaches
    Fakultät für Medizin Lehrstuhl für molekulare Allergologie Improved Diagnosis and Therapy of Hymenoptera Venom Allergy by Component-Resolved Approaches Maximilian Schiener Vollständiger Abdruck der von der Fakultät für Medizin der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) genehmigten Dissertation. Vorsitzende: Prof. Dr. Christina Zielinski Prüfende/-r der Dissertation: 1. Priv.-Doz. Dr. Simon Blank 2. Prof. Dr. Michael Sattler Die Dissertation wurde am 23.01.2018 bei der Technischen Universität München eingereicht und durch die Fakultät für Medizin am 04.07.2018 angenommen. Abstract Patients suffering from allergies due to stings of Hymenoptera like Apis mellifera, Vespula vulgaris and Polistes dominula can experience severe to fatal anaphylactic reactions. Be- sides emergency treatment, venom immunotherapy (VIT) is the only curative treatment. VIT products are available from different manufactures and treatment efficacy is very high compared to other forms of allergen-specific immunotherapy. Nevertheless, thera- peutic failures can be observed and possibly originate from different venom extraction or work-up techniques. To reduce the cost resulting from unnecessary treatment with more than one venom and to avoid the chance of de novo sensitization, the identification of the insect causing the systemic reaction has to be unambiguous. Not all patients can correctly identify the causative insect and, moreover, diagnosis by skin testing is not al- ways straightforward. Therefore, serum specific immunoglobulin E (sIgE) levels to crude insect venom can be determined in routine diagnosis. In the past, this was shown to have several disadvantages, as single allergens can be underrepresented in venom extracts due to low biologic availability or stability, thus patients sensitized to those allergens might be missed.
    [Show full text]
  • Ige in the Pathogenesis of SLE: from Pathogenic Role to Therapeutic Target
    antibodies Review IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target Yasmine Lamri 1,2 and Nicolas Charles 1,2,* 1 Centre de Recherche sur l’Inflammation, CNRS ERL8252 Faculté de Médecine Site Bichat, Université de Paris, INSERM UMR1149, 16 Rue Henri Huchard, F-75018 Paris, France; [email protected] 2 Laboratoire d’Excellence INFLAMEX, Université de Paris, F-75018 Paris, France * Correspondence: [email protected] Received: 22 October 2020; Accepted: 22 November 2020; Published: 8 December 2020 Abstract: Systemic lupus erythematosus (SLE) is a multifactorial chronic autoimmune disease, marked by the presence of autoantibodies to nuclear antigens belonging to different isotype classes. For several years, IgE antibodies have been incriminated in the development of allergic diseases and parasitic infections and different anti-IgE therapies have been developed to encounter the pathogenic role of IgE in these pathologies. Recently, multiple studies showed the presence of elevated total IgE levels and demonstrated a pathogenic role of autoreactive IgE in SLE. This review aims to summarize the findings incriminating IgE and autoreactive IgE in the pathophysiology of SLE, to describe their functional outcomes on their targeted cells as well as to discuss different IgE-related therapeutic modalities that emerged and that may be beneficial for SLE patient care. Keywords: autoantibodies; isotypes; lupus; SLE; Fc receptors; IgE; basophils; plasmacytoid dendritic cells 1. Introduction Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that predominantly affects women of childbearing age. The etiology of SLE is multifactorial and includes environmental, genetic and hormonal factors. SLE evolves by flares that can be triggered by environmental stimuli such as sun exposure or viral infections [1].
    [Show full text]
  • Basophil Activation Receptors Inhibit Mouse and Human Γ Fc
    Fcγ Receptors Inhibit Mouse and Human Basophil Activation Lydie Cassard, Friederike Jönsson, Ségolène Arnaud and Marc Daëron This information is current as of September 24, 2021. J Immunol 2012; 189:2995-3006; Prepublished online 20 August 2012; doi: 10.4049/jimmunol.1200968 http://www.jimmunol.org/content/189/6/2995 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2012/08/20/jimmunol.120096 Material 8.DC1 References This article cites 61 articles, 24 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/189/6/2995.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 24, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Fcg Receptors Inhibit Mouse and Human Basophil Activation Lydie Cassard,*,†,1 Friederike Jo¨nsson,*,†,1 Se´gole`ne Arnaud,*,† and Marc Dae¨ron*,† Besides high-affinity IgE receptors (Fc«RI), human basophils express activating (FcgRIIA) and inhibitory (FcgRIIB) low-affinity IgG receptors.
    [Show full text]
  • BASOPHIL ACTIVATION TESTING of Adults and Children Do Have a Food Allergy1
    BasophilBasophil ActivationActivation TestingTesting An in vitro test for the diagnosis of IgE and non-IgE mediated allergies Alpha Laboratories Ltd. Diagnostics 2018 A Safer Allergy Testing Alternative for Your Patients A Safer Alternative for Allergy Testing 2 A Proposed Patient Pathway for Allergy 2-3 Introducing Flow CAST® Basophil Activation Test 3 Allergy Testing- Without the Risk 4 Case Study - University Hospital Southampton Diagnosing Drug Allergy: A Rational Approach 5-6 Expert Opinion - Dr Cathy van Rooyen BÜHLMANN Allergens List 7-8 A Safer Alternative for Allergy Testing The physical symptoms of allergy can be similar BAT is a safer alternative to a provocation to those of a sensitivity or intolerance. Roughly challenge for your patient. Offering BAT before 20% of the population experience symptoms a challenge test will significantly reduce the that make them believe they have a food allergy. number of patients having to undertake a However, it is estimated that actually only 1-10% provocation challenge. For example a peanut BASOPHIL ACTIVATION TESTING of adults and children do have a food allergy1. study undertaken by Santos et al. has shown a 67% reduction in the need for oral food 3 INTRODUCTION Less than 10% of people who think they are challenge by using BAT as the primary test. allergic to penicillin are truly allergic. If someone Eliminating the need for a provocation challenge For over 40 years Alpha Laboratories is labelled as penicillin allergic they are likely to improves patient safety and comfort. be treated with broad-spectrum antibiotics2. An has been providing quality supply incorrect label of penicillin allergy may lead to The true value of BAT lies in its high specificity, and support to UK and international inappropriate use of broad-spectrum antibiotics, (reaching 100% in some studies3).
    [Show full text]